Comer SD - Search Results

1

Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment.

Comer SD, Cahill CM. Comer SD, et al. Neurosci Biobehav Rev. 2019 Nov;106:49-57. doi: 10.1016/j.neubiorev.2018.12.005. Epub 2018 Dec 5. Neurosci Biobehav Rev. 2019. PMID: 30528374 Free PMC article. Review.

2

Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.

Greenwald MK, Comer SD, Fiellin DA. Greenwald MK, et al. Among authors: comer sd. Drug Alcohol Depend. 2014 Nov 1;144:1-11. doi: 10.1016/j.drugalcdep.2014.07.035. Epub 2014 Aug 19. Drug Alcohol Depend. 2014. PMID: 25179217 Free PMC article. Review.

3

Sustained-release naltrexone: novel treatment for opioid dependence.

Comer SD, Sullivan MA, Hulse GK. Comer SD, et al. Expert Opin Investig Drugs. 2007 Aug;16(8):1285-94. doi: 10.1517/13543784.16.8.1285. Expert Opin Investig Drugs. 2007. PMID: 17685876 Review.

4

Abuse liability of oxycodone as a function of pain and drug use history.

Comer SD, Sullivan MA, Vosburg SK, Kowalczyk WJ, Houser J. Comer SD, et al. Drug Alcohol Depend. 2010 Jun 1;109(1-3):130-8. doi: 10.1016/j.drugalcdep.2009.12.018. Epub 2010 Jan 15. Drug Alcohol Depend. 2010. PMID: 20079977 Free PMC article.

5

Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Comer SD, Bickel WK, Yi R, de Wit H, Higgins ST, Wenger GR, Johanson CE, Kreek MJ. Comer SD, et al. Behav Pharmacol. 2010 Jul;21(4):251-77. doi: 10.1097/FBP.0b013e32833bb9f8. Behav Pharmacol. 2010. PMID: 20664330 Free PMC article.

6

Polydrug abuse: a review of opioid and benzodiazepine combination use.

Jones JD, Mogali S, Comer SD. Jones JD, et al. Among authors: comer sd. Drug Alcohol Depend. 2012 Sep 1;125(1-2):8-18. doi: 10.1016/j.drugalcdep.2012.07.004. Epub 2012 Aug 2. Drug Alcohol Depend. 2012. PMID: 22857878 Free PMC article. Review.

7

Opioid-like effects of the neurokinin 1 antagonist aprepitant in patients maintained on and briefly withdrawn from methadone.

Jones JD, Speer T, Comer SD, Ross S, Rotrosen J, Reid MS. Jones JD, et al. Among authors: comer sd. Am J Drug Alcohol Abuse. 2013 Mar;39(2):86-91. doi: 10.3109/00952990.2012.762372. Am J Drug Alcohol Abuse. 2013. PMID: 23421568 Free PMC article. Clinical Trial.

8

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, Cooper ZD, Manubay JM, Mogali S, Comer SD. Roux P, et al. Among authors: comer sd. Pain. 2013 Aug;154(8):1442-8. doi: 10.1016/j.pain.2013.05.004. Epub 2013 May 7. Pain. 2013. PMID: 23707283 Free PMC article.

9

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users.

Jones JD, Sullivan MA, Vosburg SK, Manubay JM, Mogali S, Metz V, Comer SD. Jones JD, et al. Among authors: comer sd. Addict Biol. 2015 Jul;20(4):784-98. doi: 10.1111/adb.12163. Epub 2014 Jul 25. Addict Biol. 2015. PMID: 25060839 Free PMC article. Clinical Trial.

10

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.

Jones JD, Sullivan MA, Manubay JM, Mogali S, Metz VE, Ciccocioppo R, Comer SD. Jones JD, et al. Among authors: comer sd. Physiol Behav. 2016 May 15;159:33-9. doi: 10.1016/j.physbeh.2015.10.006. Epub 2015 Oct 9. Physiol Behav. 2016. PMID: 26455893 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page